BioLife Solutions, SAVSU Technologies Announce Distribution Agreement

BioLife Solutions, Inc.

, a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media products for cells and tissues, and contract aseptic media manufacturer, and SAVSU Technologies, Inc., a subsidiary of Barson Corporation, today jointly announced an agreement wherein BioLife will exclusively market and distribute SAVSU's proprietary precision thermal packaging products to the stem cells and regenerative medicine markets. Mike Rice, BioLife Solutions President and CEO, stated, "This agreement represents another step to expand our best-in-class biopreservation tools portfolio.  SAVSU's precision thermal packaging products ensure temperature stability that is another important element in the continuum of biologistics of precious human cells and tissues. This partnership will expand opportunities for BioLife to help our customers further optimize and improve the critical yield and cost dynamics of transporting biologic source materials and manufactured cell and tissue products within a required and validated temperature range." The regenerative medicine market is expected to grow to more than $35 billion by 2019, according to TriMark Publications' recently published